Fierce Pharma

APRIL 12, 2024

Davis, 57, received a 9% bump in pay in 2023 to $20.3 . | Merck CEO Robert Davis has cracked the $20-million mark in annual pay for the first time, putting him in an exclusive club of biopharma heavy hitters. million, according to the company’s proxy filing.

Biopharma 224

Biopharma 224

Fierce Pharma

DECEMBER 20, 2023

Following an IPO and ahead of its fiscal 2023 earnings release next month, German drug containment and delivery specialist Schott Pharma is trumpeting its recent momentum. | Following an IPO and ahead of its fiscal 2023 earnings release next month, pharma glass specialist Schott Pharma is trumpeting its recent momentum.

Pharma 208

Pharma Sales 208

Fierce Pharma

FEBRUARY 1, 2024

With Merck reporting a whopping $25 billion sales haul for | With Merck reporting a whopping $25 billion sales haul for Keytruda on Thursday, the PD-1 cancer superstar appears to be the world’s top-selling drug in 2023. billion in 2022 and $55.1 billion in 2021.

Sales 294

Sales 294

Fierce Pharma

JANUARY 9, 2023

in COVID vaccine sales last year, projects at least $5B in 2023. Mon, 01/09/2023 - 10:34. JPM23: Moderna reaped $18.4B

Sales 320

Sales 320

Fierce Pharma

APRIL 16, 2024

million for joining Biogen as the CEO in late 2022, Chris Viehbacher saw his 2023 pay drop to $4.1 million for joining Biogen as the CEO in late 2022, Chris Viehbacher saw his 2023 pay drop to just $4.1 After getting a fat check worth $30.5 million as the Big Biotech continues to struggle. After getting a fat check worth $30.5

143

143

Fierce Pharma

JANUARY 11, 2023

Lilly, Biogen and more gear up for blockbuster launches in 2023: report. Wed, 01/11/2023 - 10:19.

262

262

Fierce Pharma

DECEMBER 20, 2023

Explore the 2023 PV Industry Survey and learn about the pivotal shifts in drug safety practices, from automation to the emergence of Gen AI. In the dynamic realm of healthcare, ensuring drug safety stands as an absolute priority for life sciences companies. Read now.

Safety 130

Safety Healthcare Healthcare 130

Fierce Pharma

APRIL 13, 2023

With Wegovy supply unfettered, Novo Nordisk ratchets up its 2023 growth forecast fkansteiner Thu, 04/13/2023 - 17:23

223

223

Fierce Pharma

OCTOBER 2, 2023

After laying out a goal to launch four new drugs in 2023, Eli Lilly has run into yet another regulatory snag. | The FDA has rejected Lilly’s investigational atopic dermatitis treatment lebrikizumab over findings uncovered during the inspection of a third-party contract manufacturing organization.

FDA 233

FDA Manufacturing 233

Fierce Pharma

NOVEMBER 6, 2023

Following suit with other companies that produce COVID-19 vaccines, BioNTech has discovered demand for its Pfizer-partnered, omicron-adapted shot has not met expectations this fall and has had to a | BioNTech has slashed its estimate of 2023 revenue by 20%, now expecting it to reach 4 billion euros ($4.3

Sales 222

Sales 222

PM360

MAY 15, 2023

Read more Digital Crusaders ELITE 2023 Digital Crusader Don Abramo of Pharming Healthcare Inc. Transformational Leaders: People who change the way companies operate.

Education 105

Education Media Marketing Sales 105

Fierce Pharma

MARCH 2, 2023

Merck KGaA, Haleon warn of more inflation challenges in 2023 fkansteiner Thu, 03/02/2023 - 09:07

201

201

European Pharmaceutical Review

JANUARY 29, 2024

N-Nitrosamines By far the biggest issue bedevilling industry during 2023 was the continuing N-nitrosamine contamination saga, which was covered in the third issue of EPR 2023. During August 2023 the FDA also updated its guidance for NDSRIs 7 and it was closely aligned (but not identical) to EMA’s evolving guidance.

Pharmaceutical 111

Pharmaceutical Food and Drug Administration Medicine FDA 111

Fierce Pharma

FEBRUARY 15, 2023

Grifols jumps pharma's 2023 layoff queue with plans to scrap 2,300 jobs, primarily in the US fkansteiner Wed, 02/15/2023 - 17:20

Pharma 236

Pharma 236

Fierce Pharma

FEBRUARY 10, 2023

Patient-First, Patient-Focused: Rare Disease Day 2023 jpiatt Fri, 02/10/2023 - 13:35

Patients 187

Patients 187

Fierce Pharma

FEBRUARY 28, 2023

Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023 kdunleavy Tue, 02/28/2023 - 11:14

Sales 201

Sales 201

Fierce Pharma

JANUARY 5, 2023

Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report. Thu, 01/05/2023 - 16:33.

Pharma 215

Pharma 215

Fierce Pharma

DECEMBER 13, 2022

Eli Lilly says 4 new launches will help drive its 2023 revenue past $30B. Tue, 12/13/2022 - 12:29.

278

278

pharmaphorum

JANUARY 8, 2023

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday. The post JP Morgan 2023 – Pre event appeared first on. We’ll also wander over to the UC Davis Health Future & Health CEO Summit a little later this afternoon.

Pharma 115

Pharma Pharmaceutical Healthcare Healthcare 115

European Pharmaceutical Review

SEPTEMBER 18, 2023

The European Medicines Agency (EMA)’s human medicines committee (CHMP) recommended nine new medicines for approval during its meeting in September 2023. This adapted Comirnaty vaccine received a positive opinion on 30 August 2023. The committee recommended granting a marketing authorisation for Ebglyss (lebrikizumab). subvariant.

Medicine 97

Medicine Marketing Management Pharmaceutical 97

pharmaphorum

JANUARY 9, 2023

The post JP Morgan 2023 – Day 1 appeared first on. Then in the evening, we’ll be at STAT@JPM for presentations by event sponsor GSK as well as the guest of honour: FDA Commissioner Robert Califf. Check below for updates throughout the day.

FDA 116

FDA Healthcare Healthcare 116

MedCity News

JANUARY 10, 2024

In 2023, digital health fundraising took on a bit of a different shape, according to a new Rock Health report. Startups tried out some creative ways to keep their businesses afloat — including series extension rounds, unlabeled fundraises and silent deals from existing investors.

132

132

European Pharmaceutical Review

AUGUST 21, 2023

For 20 of the leading biopharmaceutical companies, the second quarter (Q2) of 2023 has brought an aggregate market capitalisation growth of 2.3 trillion in the Q1 of 2023 to $3.56 trillion in Q2 2023. Q2 2023 biopharma market capitalisation results Eli Lilly “Eli Lilly witnessed the largest market capitalisation growth of 36.1

Biopharma 98

Biopharma Marketing Sales Medicine 98

pharmaphorum

DECEMBER 8, 2023

PharmStars digital health accelerator names fall 2023 grads Phil.Taylor Fri, 08/12/2023 - 14:00 Bookmark this

112

112

European Pharmaceutical Review

OCTOBER 25, 2023

CPHI Barcelona has announced the winners of 2023 CPHI Pharma Awards. These recognise outstanding achievements and contributions from the global pharmaceutical industry and supply chain across 12 broad categories.

Pharma 110

Pharma Manufacturing Management Pharmaceutical 110

European Pharmaceutical Review

NOVEMBER 14, 2023

The post Guide to Outsourcing 2023 appeared first on European Pharmaceutical Review. Sustainability in BET from your endotoxin experts Specialising in chromogenic and turbidimetric reagent technologies, Associates of Cape Cod, Inc.

Pharmaceutical 98

Pharmaceutical Pharma 98

MedCity News

DECEMBER 6, 2023

CB Insights released a list of what it deems to be the 50 most promising digital health companies of 2023. The market research firm said that the startups on the list are working to improve four main aspects of healthcare: personalization, efficiency, equity and accessibility.

Healthcare 120

Healthcare Healthcare Marketing 120

Pharmaceutical Technology

FEBRUARY 1, 2024

Novartis has announced net income soaring by 62% to $8.6bn for the full year 2023 (FY 2023) from the previous year’s $6.04bn.

98

98

Clarivate

SEPTEMBER 19, 2023

The Citation Laureates 2023 list has been announced, recognizing a select group of influential, highly cited researchers whose contributions are on par with Nobel Prize recipients. The impact on our world Citation Laureates 2023 have reshaped the boundaries of human knowledge, pushing the frontiers of what is known and what is possible.

Electronics 111

Electronics Medicine Government Patients 111

Pharmatutor

NOVEMBER 26, 2023

National Pharmacy Commission Bill, 2023 : A Critical Review admin Mon, 11/27/2023 - 12:22 ABOUT AUTHOR Dr. R. Thakur Former Secretary, Pharmacy Council of India. Email : drramsthakur@gmail.com

85

85

European Pharmaceutical Review

SEPTEMBER 15, 2023

The shortlisted finalists of the CPHI awards for 2023 include companies that led by example in sustainable manufacturing, manufacturers and innovators that developed new technologies to advance drug discovery, development and manufacturing. Are you coming to the CPHI Barcelona 2023?

Pharma 119

Pharma Manufacturing Biopharma Pharmaceutical 119

European Pharmaceutical Review

NOVEMBER 10, 2023

The post Formulation In-Depth Focus 2023 appeared first on European Pharmaceutical Review. He also highlights the industry’s gradual transition towards Definitive Screening Design, a promising development that has potential to save time and reduce costs in the pharmaceutical sector.

Manufacturing 97

Manufacturing Medical Pharmaceutical Pharma 97

PM360

APRIL 18, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the plenary sessions and speakers for its annual international conference, ISPOR 2023. The conference is scheduled for May 7-10 in Boston, MA, USA with the theme, “Impacting Innovation, Value, and Healthcare Decision Making.”

Electronics 97

Electronics Healthcare Healthcare Medicine 97

pharmaphorum

JANUARY 10, 2023

Fierce’s event “The long haul: How pharma and healthcare can survive in 2023” will feature guests from Bayer, Takeda, Genentech, and more. The post JP Morgan 2023 – Day 2 appeared first on. We’ll do our best to surf between the two, as well as providing remote updates where we can from the main event.

Healthcare 97

Healthcare Healthcare Pharma 97

Clarivate

FEBRUARY 27, 2024

Would 2023 data show a second year of decline, indicating uncertain economic outlooks? It covers a commercial market with 27 member countries, a population of over 450 million people (larger than the United States), and an economy estimated to have a combined GDP of over $ 18 trillion USD in 2023 (larger than Mainland China).

Marketing 98

Marketing Leads Management 98

European Pharmaceutical Review

DECEMBER 18, 2023

At the beginning of this year, EPR reported on the potential blockbuster pharmaceutical drugs to watch in 2023. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry. Since then, EPR has covered developments for several of the therapies highlighted in the report.

Manufacturing 98

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 98

European Pharmaceutical Review

SEPTEMBER 4, 2023

Maciej Adamczyk and Monika Pyzio-Michalik, DBS Law Firm EVENT PREVIEW Modern methods in microbiology and analytics PharmaLab Congress DRUG DELIVERY Dry powder delivery to the lungs Jnanadeva Bhat, ACG EVENT PREVIEW CPHI Barcelona 2023: what to expect Featuring company profiles from BioSpectra, Lonza and Ajinomoto VACCINE DEVELOPMENT The imperative (..)

Pharmaceutical 97

Pharmaceutical Consulting Prescription 97